Experiments demonstrated that the IL-1R antagonist anakinra inhibited tumor growth, lymphangiogenesis, and LNM by suppressing VEGF-A and VEGF-C expression, and levels of CXC chemokines in macrophages co-cultured with highly metastatic cancer cells [95]. This evidence concerns the gene VEGFC and cancer.